Beta
Trial Radar KI
enums.trial_summary.trial_summary_welcome
Eine Studie entspricht den Filterkriterien
Kartenansicht

Brain Blood Flow and Lactate in Non-obese and Obese Subjects

Offene Rekrutierung
Die Details der klinischen Studie sind hauptsächlich auf Englisch verfügbar. Trial Radar KI kann jedoch helfen! Klicken Sie einfach auf 'Studie erklären', um die Informationen zur Studie in der ausgewählten Sprache anzuzeigen und zu besprechen.
Die klinische Studie NCT06791837 ist eine beobachtungsstudie zur Untersuchung von Diabetes, Fettleibigkeit und hat den Status offene rekrutierung. Die Studie startete am 1. Mai 2025 und soll 24 Teilnehmer aufnehmen. Durchgeführt von Universität Missouri-Columbia ist der Abschluss für 1. März 2027 geplant. Die Daten von ClinicalTrials.gov wurden zuletzt am 26. November 2025 aktualisiert.
Kurzbeschreibung
Cerebral blood flow (CBF) is essential for maintaining brain health and function, as it ensures delivery oxygen and nutrients necessary to support neuronal activity. Reduced CBF can impair the brain's ability to meet its metabolic demands, leading to deficits in cognitive ability. Impairments in CBF are associated with cognitive decline and neurodegenerative disease such as Alzheimer's and dementia. Many factors influence CBF, but recently lactate has emerged as a key player. Blood glucose has long been considered the primary fuel for the brain, but emerging evidence indicates that lactate may be the preferred fuel for neurons, and lactate may become even more important under stressful conditions.

Individuals with obesity often have impaired lactate metabolism resulting in higher resting blood lactate concentrations and reduced ability to clear lactate after a physiological stress. At the same time, it is known that exercise is a powerful intervention for improving lactate metabolism.

Thus, this project seeks to investigate the role of lactate in brain blood flow in individuals with and without obesity as well as establish if short term exercise training (individuals with obesity only) will alter circulating lactate concentrations at rest and in response to exercise.

Ausführliche Beschreibung
Blood lactate is often considered a waste product from aerobic metabolism. Many people assume it causes fatigue and muscle. Lactate is a signaling molecule in the body. In addition lactate is also a fuel. Evidence supports that lactate may be more important when the brain is stressed. We also know that individuals with obesity and/or type 2 diabetes may have impaired lactate metabolism.

The investigators will compare brain blood flow and lactate response to an exercise stress test and submaximal exercise in obese and non-obese individuals.

Offizieller Titel

Cerebral Lactate Uptake and Transport in Obese and Non-Obese Individuals

Erkrankungen
DiabetesFettleibigkeit
Publikationen
Wissenschaftliche Artikel und Forschungspapiere zu dieser klinischen Studie:
Weitere Studien-IDs
  • 2125746
NCT-Nummer
Studienbeginn (tatsächlich)
2025-05-01
Zuletzt aktualisiert
2025-11-26
Studienende (vorauss.)
2027-03-01
Geplante Rekrutierung
24
Studientyp
Beobachtungsstudie
Status
Offene Rekrutierung
Stichwörter
lactate
obesity
exercise
Studienarme/Interventionen
Teilnehmergruppe/StudienarmIntervention/Behandlung
non-obese
individuals with a BMI\<25 kg/m2
Übung
each group will undergo a max test and a submaximal exercise test
obese
individuals with a BMI 30-40 kg/m2
Übung
each group will undergo a max test and a submaximal exercise test
Hauptergebnismessungen
ErgebnismessungBeschreibung der MessungZeitrahmen
brain blood flow
Using transcranial doppler we will measure brain blood flow
over the 30 minutes of testing
Nebenergebnismessungen
ErgebnismessungBeschreibung der MessungZeitrahmen
lactate concentrations
Lactate will be measured in response to an exercise stress test as well as to a submaximal exercise bout
over ~ 60 minutes of testing
Eignungskriterien

Zugelassene Altersgruppen
Erwachsene
Mindestalter
18 Years
Zugelassene Geschlechter
Alle
Akzeptiert gesunde Freiwillige
Ja

healthy adult men and women 18-45 years of age BMI 18-40 kg/m2 not pregnant, premenopausal with regular menstrual cycles not breastfeeding non-nicotine users

medications known to affect sleep, autonomic control, blood lactate levels or metabolic, or cardiovascular function (PI discretion) self-reported history of hepatic, renal, pulmonary, cardiovascular, or neurological disease, stroke or neurovascular disease, bleeding/clotting disorders, sleep apnea or other sleep disorders, diabetes, history of alcoholism or substance abuse major cardiovascular event or surgical procedure within the past three months hypertension (>140/90 mmHg or at PIs discretion).

-

University of Missouri-Columbia logoUniversität Missouri-Columbia95 aktive klinische Studien zum Erkunden
Verantwortliche Partei
Jill Kanaley, Hauptprüfer, professor, University of Missouri-Columbia
Zentrale Studienkontakte
Kontakt: Matt McDonald, MS, 6185815501, [email protected]
Kontakt: Jill Kanaley, PhD, 5738822519, [email protected]
1 Studienstandorte in 1 Ländern

Missouri

University of Missouri, Columbia, Missouri, 65211, United States
Matt McDonald, MS, Kontakt, 618-581-5501, [email protected]
Jill Kanaley, PhD, Kontakt, 5738822519, [email protected]
Jill Kanaley, PhD, Hauptprüfer
Offene Rekrutierung